Legis Daily

Freedom from Price Gouging Act

USA116th CongressHR-4663| House 
| Updated: 10/14/2019
Katie Porter

Katie Porter

Democratic Representative

California

Cosponsors (3)
Earl Blumenauer (Democratic)Jason Crow (Democratic)Lauren Underwood (Democratic)

Ways and Means Committee, Health Subcommittee, Health Subcommittee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Freedom from Price Gouging Act This bill requires drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services for covered drugs under Medicare that cost $100 or more and for which the average manufacturer price increases faster than inflation.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Oct 11, 2019
Introduced in House
Oct 11, 2019
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Oct 11, 2019
Referred to the Subcommittee on Health.
Oct 14, 2019
Referred to the Subcommittee on Health.
  • October 11, 2019
    Introduced in House


  • October 11, 2019
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • October 11, 2019
    Referred to the Subcommittee on Health.


  • October 14, 2019
    Referred to the Subcommittee on Health.

Health

Related Bills

  • HR 116-3: Elijah E. Cummings Lower Drug Costs Now Act
Civil actions and liabilityCongressional oversightGovernment studies and investigationsHealth care costs and insuranceInflation and pricesMedicarePrescription drugs

Freedom from Price Gouging Act

USA116th CongressHR-4663| House 
| Updated: 10/14/2019
Freedom from Price Gouging Act This bill requires drug manufacturers to issue rebates to the Centers for Medicare & Medicaid Services for covered drugs under Medicare that cost $100 or more and for which the average manufacturer price increases faster than inflation.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Oct 11, 2019
Introduced in House
Oct 11, 2019
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Oct 11, 2019
Referred to the Subcommittee on Health.
Oct 14, 2019
Referred to the Subcommittee on Health.
  • October 11, 2019
    Introduced in House


  • October 11, 2019
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • October 11, 2019
    Referred to the Subcommittee on Health.


  • October 14, 2019
    Referred to the Subcommittee on Health.
Katie Porter

Katie Porter

Democratic Representative

California

Cosponsors (3)
Earl Blumenauer (Democratic)Jason Crow (Democratic)Lauren Underwood (Democratic)

Ways and Means Committee, Health Subcommittee, Health Subcommittee, Energy and Commerce Committee

Health

Related Bills

  • HR 116-3: Elijah E. Cummings Lower Drug Costs Now Act
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Civil actions and liabilityCongressional oversightGovernment studies and investigationsHealth care costs and insuranceInflation and pricesMedicarePrescription drugs